Mono and multifaceted inhalant and/or food allergen reduction interventions for preventing asthma in children at high risk of developing asthma

被引:42
作者
Maas, T. [1 ]
Kaper, J.
Sheikh, A. [2 ]
Knottnerus, J. A.
Wesseling, G. [3 ]
Dompeling, E. [4 ]
Muris, J. W. M. [5 ]
van Schayck, C. P.
机构
[1] Maastricht Univ Med Ctr, Care & Publ Hlth Res Inst CAPHRI, Dept Gen Practice, NL-6200 MD Maastricht, Netherlands
[2] Univ Edinburgh, GP Sect, Div Community Hlth Sci, Edinburgh, Midlothian, Scotland
[3] Care & Publ Hlth Res Inst CAPHRI, Dept Resp Med, Maastricht, Netherlands
[4] Care & Publ Hlth Res Inst CAPHRI, Dept Paediat, Maastricht, Netherlands
[5] Maastricht Univ, Care & Publ Hlth Res Inst Caphri, Maastricht, Netherlands
来源
COCHRANE DATABASE OF SYSTEMATIC REVIEWS | 2009年 / 03期
关键词
PLACEBO-CONTROLLED TRIAL; HOUSE-DUST; ATOPIC DISEASE; CHILDHOOD ASTHMA; EARLY-LIFE; FOLLOW-UP; BRONCHIAL HYPERREACTIVITY; RANDOMIZED TRIAL; BIRTH-COHORT; MITE ALLERGY;
D O I
10.1002/14651858.CD006480.pub2
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background Allergen exposure is one of the environmental factors seemingly associated with the development of asthma. If asthma is a multi-factorial disease, it is hypothesised that prevention might only prove effective if most or all relevant environmental factors are simultaneously avoided. Objectives To assess effect(s) of monofaceted and multifaceted interventions compared with control interventions in preventing asthma and asthma symptoms in high risk children. Search strategy We searched the Cochrane Airways Trials Register (December 2008). Selection criteria Randomised controlled trials of allergen exposure reduction for the primary prevention of asthma in children. Interventions were multifaceted (reducing exposure to both inhalant and food allergens) or monofaceted (reducing exposure to either inhalant or food allergens) Follow up had to be from birth (or during pregnancy) up to a minimum of two years of age. Data collection and analysis We included in the analysis studies assessing the primary outcome (current diagnosis: asthma) and/or one of the secondary outcomes (current respiratory symptoms: wheezing, nocturnal coughing and dyspnoea). We pooled multifaceted and monofaceted intervention trials separately. We made an indirect comparison of their effects using tests for interaction to calculate relative odds ratios. Main results We included three multifaceted and six monofaceted intervention studies (3271 children). Physician diagnosed asthma in children less than five years, and asthma as defined by respiratory symptoms and lung function criteria in children aged five years and older, both favoured treatment with a multifaceted intervention compared to usual care (< 5 years: odds ratio (OR) 0.72, 95% confidence interval (CI) 0.54 to 0.96, and > 5 years: OR 0.52, 95% CI 0.32 to 0.85). However, there was no significant difference in outcome between monofaceted intervention and control interventions (< 5 years: OR 1.12, 95% CI 0.76 to 1.64, and > 5 years: OR 0.83, 95% CI 0.59 to 1.16). Indirect comparison between these treatments did not demonstrate a significant difference between multiple interventions and mono-interventions in reducing the frequency of asthma diagnosis in children under five years (relative OR 0.64 (95% CI 0.40 to 1.04, P = 0.07) or five years and older (relative OR 0.63, 95% CI 0.35 to 1.13, P = 0.12). There was also no significant difference between either mono- and multifaceted intervention and control in reducing the likelihood of symptoms of nocturnal coughing at follow up. Wheezing, however, showed a significant difference between multifaceted and mono- interventions (relative OR 0.59, 95% CI 0.35 to 0.99, P = 0.04), but the significance was lost when data on treatment only was analysed. Authors' conclusions The available evidence suggests that the reduction of exposure to multiple allergens compared to usual care reduces the likelihood of a current diagnosis of asthma in children (at ages < 5 years and 5 years and older). Mono-intervention studies have not produced effects which are statistically significant compared with control. In children who are at risk of developing childhood asthma, multifaceted interventions, characterised by dietary allergen reduction and environmental remediation, reduce the odds of a physician diagnosis of asthma later in childhood by half. This translates to a number needed to treat (NNT) of 17. The effect of multi-faceted interventions on parent reported wheeze was inconsistent and had no significant impact on nocturnal coughing or dyspnoea. Data from monofaceted intervention exposed children studies were not significantly different from those of control groups for all outcomes. There remains uncertainty as to whether multiple interventions are more effective than mono- component interventions. The comparisons made were indirect, making the conclusions drawn uncertain. To our knowledge there are no ongoing studies in which both intervention strategies are randomly compared. The findings, however, warrant further direct comparison between multiple- and monofaceted interventions aimed at reducing the prevalence of asthma in children.
引用
收藏
页数:67
相关论文
共 22 条
  • [1] Does reduction of mite allergen exposure protect children from asthma?
    Grueber, C.
    Hirsch, T.
    ALLERGOLOGIE, 2016, 39 (04) : 160 - 167
  • [2] Weighted Road Density and Allergic Disease in Children at High Risk of Developing Asthma
    Hansell, Anna L.
    Rose, Nectarios
    Cowie, Christine T.
    Belousova, Elena G.
    Bakolis, Ioannis
    Ng, Kitty
    Toelle, Brett G.
    Marks, Guy B.
    PLOS ONE, 2014, 9 (06):
  • [3] Indoor allergen exposure, sensitization, and development of asthma in a high-risk birth cohort
    Carlsten, Chris
    Dimich-Ward, Helen
    Becker, Allan B.
    Ferguson, Alexander
    Chan, Henry W.
    DyBuncio, Anne
    Chan-Yeung, Moira
    PEDIATRIC ALLERGY AND IMMUNOLOGY, 2010, 21 (04) : E740 - E746
  • [4] Coordinated Asthma Program Improves Asthma Outcomes in High-Risk Children
    Holder-Niles, Faye
    Haynes, Linda
    D'Couto, Helen
    Hehn, Rebecca S.
    Graham, Dionne A.
    Wu, Ann Chen
    Cox, Joanne E.
    CLINICAL PEDIATRICS, 2017, 56 (10) : 934 - 941
  • [5] Improving asthma communication in high-risk children
    Butz, Arlene M.
    Walker, Jennifer
    Land, Cassia Lewis
    Vibbert, Carrie
    Winkelstein, Marilyn
    JOURNAL OF ASTHMA, 2007, 44 (09) : 739 - 745
  • [6] Association between endotoxin and mite allergen exposure with asthma and specific sensitization at age 7 in high-risk children
    Carlsten, Chris
    Ferguson, Alexander
    Dimich-Ward, Helen
    Chan, Henry
    DyBuncio, Anne
    Rousseau, Roxanne
    Becker, Allan
    Chan-Yeung, Moira
    PEDIATRIC ALLERGY AND IMMUNOLOGY, 2011, 22 (03) : 320 - 326
  • [7] Predicting asthma in preschool children at high risk presenting in primary care: development of a clinical asthma prediction score
    van der Mark, Lonneke B.
    van Wonderen, Karina E.
    Mohrs, Jacob
    van Aalderen, Wim M. C.
    ter Riet, Gerben
    Bindels, Patrick J. E.
    PRIMARY CARE RESPIRATORY JOURNAL, 2014, 23 (01): : 52 - 59
  • [8] Risk factors of developing asthma in children with recurrent wheezing in the first three years of life
    Alvarez, N. Cortes
    Mateos, M. A. Martin
    Martin, A. M. Plaza
    Munoz, M. T. Giner
    Piquer, M.
    Martinez, J. I. Sierra
    ALLERGOLOGIA ET IMMUNOPATHOLOGIA, 2007, 35 (06) : 228 - 231
  • [9] Growth of preschool children at high risk for asthma 2 years after discontinuation of fluticasone
    Guilbert, Theresa W.
    Mauger, David T.
    Allen, David B.
    Zeiger, Robert S.
    Lemanske, Robert F., Jr.
    Szefler, Stanley J.
    Strunk, Robert C.
    Bacharier, Leonard B.
    Covar, Ronina
    Sorkness, Christine A.
    Taussig, Lynn M.
    Martinez, Fernando D.
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2011, 128 (05) : 956 - U386
  • [10] Development of a Symptom-Based Tool for Screening of Children at High Risk of Preschool Asthma
    Reyna, Myrtha E.
    Dai, Ruixue
    Tran, Maxwell M.
    Breton, Vanessa
    Medeleanu, Maria
    Lou, Wendy Y. W.
    Foong, Rachel E.
    Emmerson, Melanie
    Dharma, Christoffer
    Miliku, Kozeta
    Lefebvre, Diana L.
    Simons, Elinor
    Azad, Meghan B.
    Chan-Yeung, Moira
    Becker, Allan B.
    Mandhane, Piush J.
    Turvey, Stuart E.
    Hall, Graham L.
    Moraes, Theo J.
    Sears, Malcolm R.
    Subbarao, Padmaja
    JAMA NETWORK OPEN, 2022, 5 (10) : E2234714